Nanga Ravi Prakash Reddy, Brender Jeffrey R, Xu Jiadi, Veglia Gianluigi, Ramamoorthy Ayyalusamy
Department of Biophysics and Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1055, USA.
Biochemistry. 2008 Dec 2;47(48):12689-97. doi: 10.1021/bi8014357.
Disruption of the cellular membrane by the amyloidogenic peptide IAPP (or amylin) has been implicated in beta-cell death during type 2 diabetes. While the structure of the mostly inert fibrillar form of IAPP has been investigated, the structural details of the highly toxic prefibrillar membrane-bound states of IAPP have been elusive. A recent study showed that a fragment of IAPP (residues 1-19) induces membrane disruption to a similar extent as the full-length peptide. However, unlike the full-length IAPP peptide, IAPP(1-19) is conformationally stable in an alpha-helical conformation when bound to the membrane. In vivo and in vitro measurements of membrane disruption indicate the rat version of IAPP(1-19), despite differing from hIAPP(1-19) by the single substitution of Arg18 for His18, is significantly less toxic than hIAPP(1-19), in agreement with the low toxicity of the full-length rat IAPP peptide. To investigate the origin of this difference at the atomic level, we have solved the structures of the human and rat IAPP(1-19) peptides in DPC micelles. While both rat and human IAPP(1-19) fold into similar mostly alpha-helical structures in micelles, paramagnetic quenching NMR experiments indicate a significant difference in the membrane orientation of hIAPP(1-19) and rIAPP(1-19). At pH 7.3, the more toxic hIAPP(1-19) peptide is buried deeper within the micelle, while the less toxic rIAPP(1-19) peptide is located at the surface of the micelle. Deprotonating H18 in hIAPP(1-19) reorients the peptide to the surface of the micelle. This change in orientation is in agreement with the significantly reduced ability of hIAPP(1-19) to cause membrane disruption at pH 6.0. This difference in peptide topology in the membrane may correspond to similar topology differences for the full-length human and rat IAPP peptides, with the toxic human IAPP peptide adopting a transmembrane orientation and the nontoxic rat IAPP peptide bound to the surface of the membrane.
淀粉样生成肽IAPP(或胰岛淀粉样多肽)对细胞膜的破坏作用被认为与2型糖尿病期间的β细胞死亡有关。虽然已对大多呈惰性的IAPP纤维状形式的结构进行了研究,但IAPP高毒性的原纤维前体膜结合状态的结构细节仍不清楚。最近的一项研究表明,IAPP的一个片段(1-19位残基)诱导的膜破坏程度与全长肽相似。然而,与全长IAPP肽不同的是,IAPP(1-19)与膜结合时以α螺旋构象存在,构象稳定。体内和体外膜破坏测量表明,大鼠版本的IAPP(1-19),尽管与hIAPP(1-19)仅在18位残基上存在单取代差异(大鼠为Arg18,人类为His18),但其毒性显著低于hIAPP(1-19),这与全长大鼠IAPP肽的低毒性一致。为了在原子水平上研究这种差异的根源,我们解析了人源和大鼠源IAPP(1-19)肽在二棕榈酰磷脂酰胆碱(DPC)胶束中的结构。虽然大鼠和人源IAPP(1-19)在胶束中都折叠成类似的主要为α螺旋的结构,但顺磁猝灭核磁共振实验表明,hIAPP(1-19)和rIAPP(1-19)在膜中的取向存在显著差异。在pH 7.3时,毒性更强的hIAPP(1-19)肽更深地埋在胶束内部,而毒性较小的rIAPP(1-19)肽位于胶束表面。使hIAPP(1-19)中的H18去质子化会使该肽重新定位到胶束表面。这种取向变化与hIAPP(1-19)在pH 6.0时引起膜破坏的能力显著降低相一致。膜中肽拓扑结构的这种差异可能对应于全长人源和大鼠源IAPP肽的类似拓扑结构差异,即毒性较强的人源IAPP肽采取跨膜取向,而无毒的大鼠IAPP肽与膜表面结合。